TriRx Pharmaceutical Services, LLC’s Post

Explore the implications of the Biden Administration's negotiated Maximum Fair Prices (MFPs) in our crisp, informative article. Discover how these prices will affect the pharmaceutical industry, save the government significant sums, and set the stage for future drug pricing negotiations. https://pwc.to/3XH29n5

Explore the implications of the Biden Administration's negotiated Maximum Fair Prices (MFPs) in our crisp, informative article. Discover how these prices will affect the pharmaceutical industry, save the government significant sums, and set the stage for future drug pricing negotiations. https://pwc.to/3yXMLKD

We worked with a $50 billion client in the pharmaceutical industry, where the head of EMEA needed to double the region’s revenue. How did we help him meet his targets? Find out in our case study below 👇 #marketprioritization #investmentstrategies #planning2025

Last month, we discussed developments in the US pharmaceutical distribution system. Now, we look at more current developments focusing on CVS Health, which is carving out a vertically integrated space at every level of pharmaceutical distribution. https://ow.ly/PV7850QphBh #intellusWW #WeAreIntellusWW #intellusYP #mrx #insights #HCinsights #IntellusMemberNews

Join Kevin Cast, Archbow Consulting, and Jason Dohm, PharmD, Viking Healthcare Solutions, at PCMA for an informative, not-to-miss speaking session on 'The Evolving Relationships of Pharmaceutical Manufacturers and PBMs.' Join us to hear about the most relevant information and upcoming changes in the PBM industry. #pharma #biotech #PBM #pcma #supplychain

I don't need to tell anyone who follows me, why misinformation is such an important issue to be aware of. The World Economic Forum say that misinformation is the world's top risk in the next two years, and that only 40% of people trust what they read in the media. One way to tackle this is to ensure that people know who and what our industry does. The Association of the British Pharmaceutical Industry (ABPI) do so much to build familiarity and trust of what we do, and so it was a pleasure to spend the time with Jill to talk about what we can and should be doing. There's no magic bullet, but building the right partnerships might have something to do with it. Please give it a listen, share your thoughts, and get in touch if you have any thoughts about how we need to re-think how we help educate the world on what we do. #WhereAbilityMeetsAgility #misinformation #communications

Definitely need to update this photo taken a lifetime ago. Before I fully understood the impact of shared human experiences, the power of listening, and possibilities that come from acknowledging the need to do better whenever we can. Even when it’s complicated. It’s personal. Help us continue to think and do differently with integrity, intention and purpose to enable meaningful solutions for patients, their care providers and society. Optimizing opportunities to advance how health data generated across the human life journey can be managed and accessed to increase health equity, build trusted partnerships, improve the patient/participant experience and enable the effective convergence of clinical care and clinical research for all patient’s. Harness the power of shared decision making and collaboration to maximize inclusive impact. #ESG #sustainability #researchanddevopment #patientfocuseddrugdevelopment #patientadvocacy #data #individualparticipantdatareturn Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) CISCRP TransCelerate BioPharma Inc. Clinical Trials Transformation Initiative (CTTI) Patrick O. Gee, Sr., PhD., JLC Applied Clinical Trials Magazine Patients As Partners in Clinical Research Community News CRAACO: Clinical Research as a Care Option Society for Clinical Research Sites (SCRS) Facilitate Project Decentralized Trials & Research Alliance (DTRA) PALADIN Consortium Amy C. Fesmire-Baus Melissa Cabral Melissa Heidelberg David Leventhal Josee Pelletier, MBA Rachael E. Nadir AMMOUR Philippe Bordes Yann Guillevic Jimmy Bechtel, MBA Véronique POINSOT Veronica P.

Discover the ultimate guide to selecting the perfect Pharma Franchise Company! Unveil expert tips and crucial factors to ensure a successful partnership in the pharmaceutical industry. Read our comprehensive blog now and make an informed decision for your business growth. https://lnkd.in/gR2FdfbA

ESG in Pharma industry On April 29th, PatientView has published the results of the latest annual ‘Corporate Reputation of Pharma’ survey (now in its 13th year). The report is based on the opinions of a record number of patient groups—2,518—from 106 countries, on the performance of the pharmaceutical industry during 2023 and early 2024. More details on the report here: https://lnkd.in/dWxhrqgt

PatientView's Corporate Reputation of Pharma survey gathers feedback from patients groups around the world, providing them a platform to share opinions directly with the pharmaceutical industry. The 2023/2024 survey is now open for responses, and available in 22 languages at the link below, to ensure your patients have a voice in the global pharma sector in 2023. https://lnkd.in/e6_rkFzE #pharma #patientadvocacy #patientcare #patientvoice